Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3156742 | 0.83 | HCAR2 (0.46) | KEAP1NFE2L2HCAR2 | |
| SCHEMBL3156753 | 0.83 | HCAR2 (0.46) | KEAP1NFE2L2HCAR2 | |
| SCHEMBL10595070 | 0.83 | HCAR2 (0.46) | KEAP1NFE2L2HCAR2 | |
| SCHEMBL2569308 | 0.81 | CTSK (0.34) | — | |
| SCHEMBL4891444 | 0.79 | — | — | |
| SCHEMBL1068194 | 0.77 | HCAR2 (0.35) | KEAP1NFE2L2HCAR2 | |
| SCHEMBL1068196 | 0.77 | HCAR2 (0.35) | KEAP1NFE2L2HCAR2 | |
| SCHEMBL10596883 | 0.75 | HCAR2 (0.54) | KEAP1NFE2L2HCAR2 | |
| SCHEMBL10595074 | 0.75 | HCAR2 (0.54) | KEAP1NFE2L2HCAR2 | |
| SCHEMBL10595078 | 0.75 | HCAR2 (0.54) | KEAP1NFE2L2HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606719-B2 | Methods and compositions comprising biodegradable cyanoacrylates | FEMASYS INC. (US) | 2026-04-21 | — | — | US | claimed |
| US-20260062590-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | FEMASYS INC (US) | 2026-03-05 | — | — | US | claimed |
| EP-4613213-A2 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | Femasys, Inc. (US) | 2025-09-10 | — | — | EP | claimed |
| EP-3579890-B1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES | FEMASYS INC (US) | 2025-06-18 | — | — | EP | claimed |
| US-20230390105-A1 | METHODS AND DEVICES FOR CONTROLLED DELIVERY | POINTILLIST GLOBAL MACRO SERIES OF POINTILLIST PARTNERS LLC | 2023-12-07 | — | — | US | claimed |
| EP-3787533-A1 | METHODS AND DEVICES FOR CONTROLLED DELIVERY | Femasys, Inc. (US) | 2021-03-10 | — | — | EP | claimed |
| WO-2018148453-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES | FEMASYS, INC. (US) | 2018-08-16 | — | — | WO | claimed |
| EP-2618741-B1 | APPLICATOR FOR DISPENSING ADHESIVE | ADHEZION BIOMEDICAL LLC (US) | 2018-04-04 | — | — | EP | claimed |
| EP-2211727-B1 | CYANOACRYLATE TISSUE ADHESIVES | ADHEZION BIOMEDICAL LLC (US) | 2014-03-12 | — | — | EP | claimed |
| US-8550737-B2 | Applicators for dispensing adhesive or sealant material | ADHEZION BIOMEDICAL, LLC (US) | 2013-10-08 | — | — | US | claimed |
| US-12606719-B2 | Methods and compositions comprising biodegradable cyanoacrylates | FEMASYS INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-12582546-B2 | Methods and devices for controlled delivery | FEMASYS INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-20260062590-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | FEMASYS INC (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4613213-A2 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | Femasys, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20250228644-A1 | METHODS FOR MARKING A TARGET LOCATION FOR A MEDICAL PROCEDURE | EPHEMERAL SOLUTIONS, INC. | 2025-07-17 | — | — | US | disclosed |
| US-20090024155-A1 | Methods and Devices for Conduit Occlusion | FEMASYS, INC. | 2009-01-22 | — | — | US | disclosed |
| US-20090024108-A1 | Methods and Devices for Delivery of Compositions to Conduits | FEMASYS, INC. | 2009-01-22 | — | — | US | disclosed |
| US-20080293872-A1 | ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER | HENKEL AG & CO. KGAA (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080287574-A1 | ADHESIVES, SEALANTS AND COATINGS CONTAINING GLASS PARTICLES AS A FILLER | HENKEL AG & CO. KGAA (DE) | 2008-11-20 | — | — | US | disclosed |
| WO-2008059541-A1 | COSMETIC PRODUCT FOR THE TREATMENT OF CICATRICIAL TISSUES | METIS S.R.L. (IT) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062590-A1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS | PGF, ACR, FGB | KEAP1 3617/4885NFE2L2 3027/4885HCAR2 465/4885 |
| US-12582546-B2 | Methods and devices for controlled delivery | PGF, GNRHR, LHCGR | KEAP1 3961/4885NFE2L2 4602/4885HCAR2 2700/4885 |
| US-12606719-B2 | Methods and compositions comprising biodegradable cyanoacrylates | MKI67, ACR, PGF | KEAP1 3017/4885NFE2L2 2639/4885HCAR2 1197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.